China fmtBank

China Microbiota Bank, also known as China fmtBank, is a leading biotechnology organization in China dedicated to the standardization and clinical implementation of Fecal Microbiota Transplantation (FMT). Operated by Nanjing FMT Medical, the company established the nation's first standardized stool bank to provide high-quality, rigorously screened microbiota for the treatment of gastrointestinal and extra-intestinal diseases. Their product portfolio includes standardized microbiota suspensions, capsules, and the proprietary GenFMTer, an automated system for microbiota purification. The bank supports an extensive network of hospitals and research institutions, facilitating clinical trials and therapeutic interventions for conditions such as Clostridioides difficile infection, inflammatory bowel disease, and autism spectrum disorder. By focusing on safety, scalability, and technological innovation, China Microbiota Bank has become a central infrastructure provider for microbiome-based therapies in Asia.